BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Essential Pharmaceuticals Acquires Exclusive Worldwide Rights to Family of Cell Media Products from Lifeblood Medical, Inc.


10/28/2010 7:06:41 AM

NEWTOWN, Pa., Oct. 27 /PRNewswire/ -- Essential Pharmaceuticals, LLC, a private company dedicated to providing specialty reagents and solutions to the life sciences market, announced today that the Company will commence sales and distribution of three distinct animal-component-free products: serum replacement, cryopreservation and clinical pathology media, formerly sold under the LiforCell® name:

  • Cell-Ess Serum Replacement cell culture medium,
  • Cryo-Ess cryopreservation medium, and
  • Clin-Ess transportation medium.

"The quality and consistency of Cell-Ess, Cryo-Ess and Clin-Ess gives scientists the confidence to conduct their research without testing each new serum lot purchased, resulting in improved laboratory efficiency and valuable cost savings," said Allan Weber, chief executive officer of Essential Pharmaceuticals. "Moreover, we believe that the characteristics of these media products offer important clinical benefits, making Cell-Ess the ideal choice for use in the cutting edge areas of stem cell, cancer and vaccine research, and Clin-Ess in the preservation of limbs and organs for surgical applications."

The Cell-Ess, Cryo-Ess and Clin-Ess family offers researchers the advantage of superior performance compared to fetal bovine serum. They are free of all animal components and dimethyl sulfoxide (DSMO), do not crystallize or form ice during the thawing process, resulting in less DNA and RNA degradation and fewer artifacts than those preserved using conventional methods. Further, they have demonstrated synthetic reproducibility with no lot-to-lot variability.

Essential Pharmaceuticals acquired exclusive worldwide rights to these media products, originally the LiforCell® family of products, from Lifeblood Medical, Inc. These cell culture and cryopreservation products have been re-branded to correlate to their specific research and clinical applications.

"Essential Pharmaceuticals is known for its outstanding customer support in highly specialized fields," stated Joseph Fischer, President and Chief Executive Officer of Lifeblood Medical. "That, along with the superior advantages of these cell culture and cryopreservation media, will generate increased growth and market penetration of the Lifeblood technology."

About Essential Pharmaceuticals

Essential Pharmaceuticals LLC, a key company in the organ transplant arena, provides Custodiol® HTK organ preservation solution to the transplant medical community. Essential is well-known for excelling in highly specialized medical areas through a combination of outstanding customer support coupled with customized distribution systems and ongoing research projects to further knowledge in the field of organ preservation. Essential plans on bringing this proven model to support medical researchers and further their projects, improving future medical discoveries globally.

For additional information about Essential Pharmaceuticals new family of cell media products, or any other Essential product, please visit our website at www.essentialpharma.com, e-mail to info@essentialpharma.com or call 1-267-757-0112.

*CUSTODIOL® HTK is a registered trademark of Dr. Franz Kohler Chemie GmbH, Alsbach-Hahnlein, Germany.

*LiforCell® is a registered trademark of Lifeblood Medical, Inc.

SOURCE Essential Pharmaceuticals, LLC



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES